BAKER BIOTECH CAPITAL II GP LLC Insider Trading $GEVA SYNAGEVA BIOPHARMA CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BIOTECH CAPITAL II GP LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BIOTECH CAPITAL II GP LLC. BAKER BIOTECH CAPITAL II GP LLC is 10% Owner in NEUROGEN CORP ($NRGN) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN).
BAKER BIOTECH CAPITAL II GP LLC in SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BAKER BIOTECH CAPITAL II GP LLC: Director
Holdings: 1,144,755 shares
Latest Transaction: Nov 02 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BAKER BIOTECH CAPITAL II GP LLC in SYNAGEVA BIOPHARMA CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, NRGN, SGEN, GEVA, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 02 2004 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Sell | J | 0.00 | 586,556 | 0 | 1,144,755 | 1.7 M to 1.1 M (-33.88 %) |
| Sep 14 2004 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 13.32 | 22,322 | 297,329 | 1,731,311 | 1.7 M to 1.7 M (+1.31 %) |
| Sep 14 2004 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 13.56 | 17,859 | 242,152 | 1,708,989 | 1.7 M to 1.7 M (+1.06 %) |
| Sep 14 2004 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 12.99 | 1,450 | 18,837 | 1,691,130 | 1.7 M to 1.7 M (+0.09 %) |
| Sep 14 2004 | GEVA | SYNAGEVA BIOPHARMA ... | BAKER BIOTECH CAPITAL II GP LL ... | Director | Buy | P | 12.55 | 33,484 | 420,348 | 1,689,680 | 1.7 M to 1.7 M (+2.02 %) |
Page: 1